Report: Life sciences securities cases increased in 2012

Securities fraud class actions against life sciences companies increased by 65 percent in 2012 compared to 2011, reversing a previous dip, according to a new Dechert report.

This article requires free registration

This article requires free registration to The National Law Journal. Please sign in or register to read the full text.